Techinvention Lifecare has been engaged by Botswana Vaccine Institute for its Veterinary Vaccine Manufacturing Facility Read more
Signet Therapeutics announces IND approval by the FDA for world’s first targeted therapy for DGC Read more
US body Clinical and Laboratory Standards Institute (CLSI) awards high susceptibility breakpoints to Zaynich (Zidebactam/Cefepime- WCK 5222) Read more